Mid-Atlantic Epilepsy and Sleep Center

Summary

Mid-Atlantic Epilepsy and Sleep Center is a medical facility located in Bethesda, Maryland. This center is recognized for care of Epilepsy, Seizures, Partial Cycloplegia, Lennox Gastaut Syndrome, Partial Seizures and other specialties. Mid-Atlantic Epilepsy and Sleep Center is involved with conducting 50 clinical trials across 33 conditions. There are 1 research doctors associated with this hospital, such as Pavel Klein.

Top PIs

Clinical Trials running at Mid-Atlantic Epilepsy and Sleep Center

Seizures

Epilepsy

Lennox Gastaut Syndrome

Partial Cycloplegia

Neurodevelopmental Disorder

Partial Seizures

Developmental Encephalopathy

Hippocampal Sclerosis

Temporal Lobe Epilepsy

Myoclonic Astatic Epilepsy

Cenobamate

for Epilepsy

Primary objective: To evaluate the safety and tolerability of cenobamate in pediatric subjects 2-17 years of age with partial-onset (focal) seizures

Recruiting

2 awards

Phase 3

12 criteria

LP352

for Epilepsy

This (DEEp OCEAN Study) is a double-blind, randomized, placebo-controlled, multicenter study to investigate the efficacy, safety, and tolerability of LP352 in the treatment of seizures in children and adults with DEE. The study consists of 3 main phases: Screening, Titration period, Maintenance period, followed by a Taper period and Follow-Up. The total duration of the study will be approximately 24 months.

Recruiting

1 award

Phase 3

3 criteria

XEN1101

for Partial Seizures

The X-TOLE3 Phase 3 clinical trial is a randomized, double-blind, placebo-controlled study that will evaluate the clinical efficacy, safety and tolerability of XEN1101 administered as adjunctive therapy in focal-onset seizures.

Recruiting

1 award

Phase 3

4 criteria